1
Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus of Coronavirus Disease 2019
Condition(s):Coronavirus Disease (COVID-19)Last Updated:February 4, 2021Completed
Coronavirus Infections: 8226 Clinical Trials, Page 1 of 823
Hide Studies Not Open or Pending
2
Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System
Condition(s):COVID19; Corona Virus Infection; Myocardial Injury; PneumoniaLast Updated:April 20, 2020Unknown status
3
Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)
Condition(s):CoronavirusLast Updated:May 9, 2023Active, not recruiting
4
Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine
Condition(s):Coronavirus Disease 2019Last Updated:November 4, 2021Recruiting
5
Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)
Condition(s):Coronavirus Disease 2019Last Updated:October 25, 2021Recruiting
6
Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunity
Condition(s):Coronavirus Disease 2019Last Updated:October 22, 2021Completed
7
Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection
Condition(s):CoronavirusLast Updated:February 24, 2020Unknown status
8
Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2（COVID-19） Phase I Clinical Trial (3~17 Years Old)
Condition(s):CoronavirusLast Updated:April 25, 2023Completed
9
Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations
Condition(s):CoronavirusLast Updated:February 21, 2020Unknown status
10
Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old)
Condition(s):CoronavirusLast Updated:January 27, 2021Unknown status